{"id":"https://openalex.org/W2189246882","doi":"https://doi.org/10.5167/uzh-117543","title":"Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma","display_name":"Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2189246882","doi":"https://doi.org/10.5167/uzh-117543","mag":"2189246882","pmid":"https://pubmed.ncbi.nlm.nih.gov/25536624"},"language":"en","primary_location":{"id":"pmid:25536624","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25536624","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2189246882"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5167/uzh-117543","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014804522","display_name":"Mihajlo B Jakovljevic","orcid":"https://orcid.org/0000-0002-9160-6846","observed_orcids":["https://orcid.org/0000-0002-9160-6846"]},"institutions":[{"id":"https://openalex.org/I14245010","display_name":"University of Kragujevac","ror":"https://ror.org/04f7vj627","country_code":"RS","type":"education","lineage":["https://openalex.org/I14245010"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Jakovljevic, Mihajlo","raw_affiliation_strings":["Department of Pharmacology and toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia","institution_ids":["https://openalex.org/I14245010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104002215","display_name":"Florian S. Gutzwiller","orcid":"https://orcid.org/0000-0001-7754-5744","observed_orcids":["https://orcid.org/0000-0001-7754-5744"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Gutzwiller, Florian","raw_affiliation_strings":["Institut f\u00fcr Pharmazeutische Medizin (ECPM), Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Pharmazeutische Medizin (ECPM), Basel, Switzerland","institution_ids":["https://openalex.org/I1850255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072254367","display_name":"Matthias M. Schwenkglenks","orcid":"https://orcid.org/0000-0001-7217-1173","observed_orcids":["https://orcid.org/0000-0001-7217-1173"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Schwenkglenks, Matthias","raw_affiliation_strings":["Institut f\u00fcr Pharmazeutische Medizin (ECPM), Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Pharmazeutische Medizin (ECPM), Basel, Switzerland","institution_ids":["https://openalex.org/I1850255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022968907","display_name":"Olivera Z. Milovanovic","orcid":"https://orcid.org/0000-0002-5593-0526","observed_orcids":["https://orcid.org/0000-0002-5593-0526"]},"institutions":[{"id":"https://openalex.org/I14245010","display_name":"University of Kragujevac","ror":"https://ror.org/04f7vj627","country_code":"RS","type":"education","lineage":["https://openalex.org/I14245010"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Milovanovic, Olivera","raw_affiliation_strings":["University of Kragujevac, Kragujevac , Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kragujevac, Kragujevac , Serbia","institution_ids":["https://openalex.org/I14245010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008647869","display_name":"Nemanja Ran\u010di\u0107","orcid":"https://orcid.org/0000-0002-5122-8094","observed_orcids":["https://orcid.org/0000-0002-5122-8094"]},"institutions":[{"id":"https://openalex.org/I4068193","display_name":"University of Belgrade","ror":"https://ror.org/02qsmb048","country_code":"RS","type":"education","lineage":["https://openalex.org/I4068193"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Rancic, Nemanja","raw_affiliation_strings":["Belgrade University School of Medicine, Belgrade, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgrade University School of Medicine, Belgrade, Serbia","institution_ids":["https://openalex.org/I4068193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051620636","display_name":"Mirjana Varja\u010di\u0107","orcid":"https://orcid.org/0000-0003-1528-9305","observed_orcids":["https://orcid.org/0000-0003-1528-9305"]},"institutions":[{"id":"https://openalex.org/I4210154797","display_name":"Clinical Centre of Kragujevac","ror":"https://ror.org/054nax084","country_code":"RS","type":"healthcare","lineage":["https://openalex.org/I4210154797"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Varjacic, Mirjana","raw_affiliation_strings":["University Clinical Center Kragujevac, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Clinical Center Kragujevac, Serbia","institution_ids":["https://openalex.org/I4210154797"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038848243","display_name":"Dobrivoje Stojadinovi\u0107","orcid":"https://orcid.org/0000-0003-1494-0573","observed_orcids":["https://orcid.org/0000-0003-1494-0573"]},"institutions":[{"id":"https://openalex.org/I4210154797","display_name":"Clinical Centre of Kragujevac","ror":"https://ror.org/054nax084","country_code":"RS","type":"healthcare","lineage":["https://openalex.org/I4210154797"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Stojadinovic, Dobrivoje","raw_affiliation_strings":["University Clinical Center Kragujevac, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Clinical Center Kragujevac, Serbia","institution_ids":["https://openalex.org/I4210154797"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001711040","display_name":"Aleksandar Dagovi\u0107","orcid":"https://orcid.org/0000-0002-4280-9831","observed_orcids":["https://orcid.org/0000-0002-4280-9831"]},"institutions":[{"id":"https://openalex.org/I4210154797","display_name":"Clinical Centre of Kragujevac","ror":"https://ror.org/054nax084","country_code":"RS","type":"healthcare","lineage":["https://openalex.org/I4210154797"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Dagovic, Aleksandar","raw_affiliation_strings":["Clinical Center Kragujevac, Belgrade, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Center Kragujevac, Belgrade, Serbia","institution_ids":["https://openalex.org/I4210154797"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086220270","display_name":"Klazien W Matter-Walstra","orcid":"https://orcid.org/0000-0002-5143-8112","observed_orcids":["https://orcid.org/0000-0002-5143-8112"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Matter-Walstra, Klazien","raw_affiliation_strings":["Institut f\u00fcr Pharmazeutische Medizin (ECPM), Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Pharmazeutische Medizin (ECPM), Basel, Switzerland","institution_ids":["https://openalex.org/I1850255"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.9712,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.96224127,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"19","issue":"4","first_page":"1111","last_page":"1120"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.8529999852180481,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.8529999852180481,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.14100000262260437,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9679999947547913},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.8429999947547913},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9139999747276306},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.984000027179718},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.7839999794960022},{"id":"https://openalex.org/keywords/productivity-costs","display_name":"productivity costs","score":0.492000013589859},{"id":"https://openalex.org/keywords/healthcare-affordability","display_name":"health care affordability","score":0.5419999957084656},{"id":"https://openalex.org/keywords/southeastern-europe","display_name":"Southeastern Europe","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9133756160736084},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8820387721061707},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.636601984500885},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6338262557983398},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6217750906944275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6204491257667542},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5408241748809814},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.5350614190101624},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.53165203332901},{"id":"https://openalex.org/C3018521938","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast carcinoma","level":4,"score":0.4735618829727173},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4681641757488251},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4625411033630371},{"id":"https://openalex.org/C2780140570","wikidata":"https://www.wikidata.org/wiki/Q3545481","display_name":"Surgical oncology","level":2,"score":0.4427739083766937},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38371866941452026},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18580907583236694}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":6,"locations":[{"id":"pmid:25536624","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25536624","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","raw_type":"Journal Article"},{"id":"pmh:oai:www.zora.uzh.ch:117543","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/id/eprint/117543/1/1111-1120.pdf","pdf_url":"https://www.zora.uzh.ch/id/eprint/117543/1/1111-1120.pdf","source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Jakovljevic, Mihajlo; Gutzwiller, Florian; Schwenkglenks, Matthias; Milovanovic, Olivera; Rancic, Nemanja; Varjacic, Mirjana; Stojadinovic, Dobrivoje; Dagovic, Aleksandar; Matter-Walstra, Klazien (2014). Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 19(4):1111-1120.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:lup.lub.lu.se:d2091169-8fda-4e45-9cd8-824cdc969bc2","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/d2091169-8fda-4e45-9cd8-824cdc969bc2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of B.U.ON.; 19(3), pp 20-1111 (2014)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/114381","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/114381","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Jakovljevic, M., Gutzwiller, F., Schwenkglenks, M., Milovanovic, O., Rancic, N., Varjacic, M., Stojadinovic, D., Dagovic, A., & Matter-Walstra, K. (2014). Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin\u2019s lymphoma. Journal of B.U.ON.\u202f: Official Journal of the Balkan Union of Oncology, 19, 1111\u20131120. http://www.jbuon.com/pdfs/1111-1120.pdf","raw_type":"Journal Article"},{"id":"doi:10.5167/uzh-117543","doi":"https://doi.org/10.5167/uzh-117543","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-117543","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"mag:2189246882","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25536624","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"doi:10.5167/uzh-117543","doi":"https://doi.org/10.5167/uzh-117543","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-117543","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W109492528","https://openalex.org/W1629918075","https://openalex.org/W1974413772","https://openalex.org/W1978338987","https://openalex.org/W1978622696","https://openalex.org/W1991527872","https://openalex.org/W1992546083","https://openalex.org/W1993853351","https://openalex.org/W2000179201","https://openalex.org/W2005638449","https://openalex.org/W2010348225","https://openalex.org/W2018033335","https://openalex.org/W2020968631","https://openalex.org/W2028587641","https://openalex.org/W2033593029","https://openalex.org/W2034779548","https://openalex.org/W2035899311","https://openalex.org/W2060479773","https://openalex.org/W2062200941","https://openalex.org/W2062565392","https://openalex.org/W2069703793","https://openalex.org/W2070088134","https://openalex.org/W2077630353","https://openalex.org/W2077952077","https://openalex.org/W2077969232","https://openalex.org/W2078177382","https://openalex.org/W2081866049","https://openalex.org/W2084945180","https://openalex.org/W2094103668","https://openalex.org/W2094962376","https://openalex.org/W2108575509","https://openalex.org/W2108880509","https://openalex.org/W2109042515","https://openalex.org/W2114901994","https://openalex.org/W2116243702","https://openalex.org/W2127113630","https://openalex.org/W2133579497","https://openalex.org/W2136060045","https://openalex.org/W2140780929","https://openalex.org/W2146210169","https://openalex.org/W2149807648","https://openalex.org/W2167984747","https://openalex.org/W2194766914","https://openalex.org/W2278975836","https://openalex.org/W2321055101","https://openalex.org/W2329337907","https://openalex.org/W2332148629","https://openalex.org/W2398547011","https://openalex.org/W2410118583","https://openalex.org/W2411324463","https://openalex.org/W2416231405","https://openalex.org/W2419198643","https://openalex.org/W2434078455","https://openalex.org/W3188378565"],"related_works":["https://openalex.org/W2014747026","https://openalex.org/W98243944","https://openalex.org/W2043070875","https://openalex.org/W1644914285","https://openalex.org/W3108204080","https://openalex.org/W2130659077","https://openalex.org/W1978324722","https://openalex.org/W2130880126","https://openalex.org/W4315778474","https://openalex.org/W2085345695"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"assess":[2],"and":[3,19,39,55,71,90,99,106,130,162,206,228],"compare":[4],"the":[5,238,247],"costs":[6,109,132,177,200,234],"of":[7,80,87,93,120,133,178,185,194,235,250],"first-line":[8,202],"monoclonal":[9],"antibodies":[10],"(mAbs)":[11],"treatment":[12,60,112,212],"protocols":[13,61,213],"in":[14,22,201,214,252],"breast":[15,138],"cancer,":[16,50,53],"non-Hodgkin":[17,56,165],"lymphoma":[18,166],"colorectal":[20,52,147,155,215],"carcinoma":[21,148,156,216],"South-Eastern":[23],"Europe.":[24],"METHODS:":[25],"A":[26],"retrospective,":[27],"bottom-up":[28],"case":[29],"series":[30],"study":[31,43],"design":[32],"was":[33,46,122,189,218],"implemented":[34],"with":[35,198],"one-year":[36],"time":[37],"horizon":[38],"payer's":[40],"perspective.":[41],"The":[42,117,181,192],"sample":[44],"size":[45],"265":[47],"patients":[48,188,217],"(breast":[49],"N=137;":[51],"N=44;":[54],"lymphoma,":[57],"N=84),":[58],"while":[59],"included":[62,78],"adjuvant":[63],"mAbs:":[64],"trastuzumab":[65,136,224],"(N=137),":[66],"bevacizumab":[67,145,226],"(N=28),":[68],"rituximab":[69,163,229],"(N=16)":[70],"cetuximab":[72,153],"(N=84).":[73],"ICD-10":[74],"related":[75],"resources":[76],"use":[77,193],"history":[79],"medical":[81,105,179,204],"services":[82],"utilization,":[83],"chronology":[84],"(time":[85],"out":[86],"service":[88],"provision)":[89],"unit":[91],"consumption":[92],"examinations,":[94],"drugs":[95],"prescribed,":[96],"imaging,":[97],"radiotherapy":[98],"surgical":[100],"procedures":[101],"provided":[102],"etc.,":[103],"direct":[104,129],"lost":[107],"productivity":[108],"(\u20ac)":[110],"across":[111],"groups":[113],"during":[114],"2010-2013.":[115],"RESULTS:":[116],"average":[118,172],"length":[119],"observation":[121],"125+97":[123],"days":[124],"per":[125,143,151,160,169],"patient.":[126,170],"Total":[127],"mean":[128],"indirect":[131],"care":[134,205],"were:":[135],"for":[137,146,154,164,240],"cancer":[139,203],"group":[140,149,157,167],"\u20ac":[141,158],"17,740":[142],"patient;":[144,152,161],"\u20ac8,775":[150],"27,181":[159],"\u20ac19,431":[168],"An":[171],"mAbs-treated":[173],"patient":[174],"incurred":[175],"\u20ac17,897":[176],"care.":[180],"total":[182],"combined":[183],"budget":[184],"these":[186],"330":[187],"\u20ac4,742,775.":[190],"CONCLUSIONS:":[191],"mAbs":[195,236],"strongly":[196],"correlated":[197],"high":[199,233],"dominated":[207],"other":[208],"cost":[209],"domains.":[210],"Cetuximab-based":[211],"substantially":[219],"more":[220],"expensive":[221],"compared":[222],"to":[223],"(C50),":[225],"(C20),":[227],"(C80)":[230],"alternatives.":[231],"Extremely":[232],"are":[237],"key-issue":[239],"Eastern":[241],"European":[242],"policy":[243],"makers":[244],"by":[245],"crossing":[246],"upper":[248],"limits":[249],"affordability":[251],"middle-income":[253],"economies.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2189246882","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
